Differences in Plaque Progression Depending on its Characteristics

The pattern of growth for each plaque differs according to the presence of certain risk factors. Atheroma volume at baseline was the most important predictor of plaque developing into obstructive lesions, as opposed to other characteristics historically considered as “dangerous.”

iFR en lesiones no culpables: el momento de la medición parece cambiar la historia

The aim of this study was to analyze whether the pattern of non-obstructive lesion progression could differ according to certain characteristics.

It is still debatable whether such characteristics simply represent a different phase during the natural history of the disease or if they can anticipate disease progression.

This prospective, multinational registry enrolled consecutive patients with non-obstructive coronary artery lesions (<50%), who underwent serial coronary computed tomography angiography at intervals at least 2 years.

High-risk plaque was defined as lesions with 2 or more of the following features: positive remodeling, calcified nodules, and hypoattenuation. Baseline quantitative angiographic percent obstruction and atheroma volume were compared over time between high-risk and non-high-risk plaque.


Read also: Subintimal Re-Entry in CTO Improves Outcomes.


A total of 3049 non-obstructive lesions were identified in 1297 patients (mean age 60.3 ± 9.3 years); 425 lesions met the high-risk criteria and 2624 did not.

Upon adjusted multivariate analysis, only baseline atheroma volume and obstruction percentage could independently predict plaque progression (p < 0.05 for both). High-risk characteristics were not associated with progression over time.

Conclusion

Each non-obstructive plaque has its own individual morphologic pattern, and only baseline atheroma volume and obstruction percentage could predict their progression over time. High-risk characteristics could not predict progression, even when considered as a composite.

Original title: Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA.

Reference: Sang-Eun Lee et al. JACC Cardiovasc Imaging. 2020 Jun;13(6):1409-1417. doi: 10.1016/j.jcmg.2019.09.011.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....